Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
CheckMate 743 研究比较了纳武利尤单抗联合伊匹木单抗与化疗作为不可切除胸膜间皮瘤一线治疗方案的五年临床结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01328
Scherpereel, Arnaud; Baas, Paul; Nowak, Anna K; Tsao, Anne S; Fujimoto, Nobukazu; Peters, Solange; Mansfield, Aaron S; Popat, Sanjay; Bautista Aragon, Yolanda; Talbot, Toby; Grossi, Francesco; Kowalski, Dariusz; Kaplan, Muhammet A; Cardona, Andrés Felipe; Soomro, Raheela; Hu, Nan; Lee, Adam; Ip, Virginia; Hung, Yu-Han; Zalcman, Gérard